Pfaudler wins contract to equip Chinese pharmaceutical plant

Published: 18-Jul-2011
Manufacturing

With glass-lined reactor vessels and thermal control units

Pfaudler, a global supplier of glass lined reactors and modular process systems for the pharmaceutical industry, has won a contract to supply 43 glass-lined reactor vessels and nine thermal control units (TCUs) to a new pharmaceutical plant in Southern China. Financial details were not disclosed.

Pfaudler-Balfour, based in Leven, Fife, Scotland has designed the TCU heating and cooling systems (design range of -29/+200°C) in close consultation with Robbins & Myers Process Solutions Group company Suzhou Pfaudler, based in China, which is manufacturing glass-lined reactor vessels (ranging from 50 to 3000L) and building the TCUs.

Pfaudler says its design-build capability and proven track record helped secure this ‘significantly large order’ for process plant equipment.

With manufacturing sites in the UK, Germany, India, China, US, Mexico and Brazil, Pfaudler supplies modular systems that incorporate products and materials from the Robbins & Myers Process Solutions Group, including reactors, condensers, utility systems, columns, evaporators and heat exchangers.

See more

You may also like

Manufacturing

Pfaudler supplies two mobile reactors to UK pharma plant

Read more
They are being used for processing solvents, acids and alkalis

Trending Articles

  1. You need to be a subscriber to read this article.
    Click here to find out more.
    Overcoming the hurdles of strategic market expansion Ramprasad Kaparaboyena, Regulatory Affairs Manager and QP for Pharmacovigilance at Gaelic Laboratories, discusses how to overcome the challenges of expanding your pharma market into new global regions
  2. Vetter Pharma to build new manufacturing site in Germany as part of €1.5bn global expansion plan The company has submitted a building permit application for a new commercial manufacturing facility in Saarland, Germany, with construction set to begin in Q2 2026 and operations planned for 2031
  3. Drug-loaded pellets: unlocking flexible oral dosage design with modern pelletisation technologies Produced using advanced extrusion–spheronisation technologies such as GEA’s NICA systems, drug-loaded pellets are gaining traction as a flexible and scalable oral solid dosage platform that enhances release control, patient outcomes and manufacturing efficiency
  4. LabIndex - Sourcing solutions powered by a network of world-class suppliers Labtex states: "Using our experience and negotiating power, we can speedily source and procure virtually any type of laboratory equipment or consumables at competitive prices."
  5. New thermal inkjet printer expands AM Labels’ coding portfolio M2 system delivers high resolution variable data printing at production-line speeds

Upcoming event

High Shear = Mixing Success

19 February 2026 | Virtual See all

You may also like

Manufacturing

Pfaudler supplies two mobile reactors to UK pharma plant

They are being used for processing solvents, acids and alkalis
Manufacturing

Bracco enters cell therapy manufacturing with microbubble-based cell selection technology

Bracco Imaging is expanding into cell therapy manufacturing with a bead-free cell selection and activation technology based on its clinically validated microbubble platform
Manufacturing

New manufacturing line from Adragos granted regulatory approval from Swissmedic

The approval of the new, state-of-the-art facility follows a comprehensive modernisation programme in 2024/2025 that has focussed on ensuring the future-readiness of the plant
Manufacturing

Freudenberg Medical launches new hydrophilic coating LUBRITEQ

The launch comes alongside a comprehensive suite of associated development and manufacturing services designed to remove commercial barriers and enable long-term, trust-based partnerships
Manufacturing

The REACTEX range - cutting-edge components, unmatched precision

Utilising cutting-edge components from leading UK and German manufacturers, the REACTEX range of interchangeable glass reactors offer the following:
Manufacturing

Drug-loaded pellets: unlocking flexible oral dosage design with modern pelletisation technologies

Produced using advanced extrusion–spheronisation technologies such as GEA’s NICA systems, drug-loaded pellets are gaining traction as a flexible and scalable oral solid dosage platform that enhances release control, patient outcomes and manufacturing efficiency
Manufacturing

Vetter Pharma to build new manufacturing site in Germany as part of €1.5bn global expansion plan

The company has submitted a building permit application for a new commercial manufacturing facility in Saarland, Germany, with construction set to begin in Q2 2026 and operations planned for 2031
Subscribe now